Professor Tom Scriba

Tom Scriba is Professor at University of Cape Town and Deputy Director (Immunology) at the South African Tuberculosis Vaccine Initiative (SATVI), where he heads a team of clinical immunologists, post-doctoral fellows and postgraduate students, focusing on the development of new and effective prevention strategies against TB. This includes research into vaccination and biomarker-targeted treatment approaches. His particular interests include immunopathology of mycobacterial infection and TB disease, correlates of risk and protection against M. tuberculosis infection and TB disease, and novel TB vaccine development. He has been co-investigator on 20 clinical trials of novel TB vaccines.